Performance IV Therapy
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
- Chelation Therapy
- Lyme Disease Treatment
Beaverton, OR
Beaverton sits in Washington County west of Portland, home to Nike's world headquarters on a 400-acre campus and the Tektronix legacy corridor. The local IV therapy market reflects an active, sports-performance-oriented demographic, with clinics catering to Nike professionals, endurance athletes training on the Tualatin Valley routes, and the broader West Hills tech cluster. Clinics cluster along Murray Boulevard, Canyon Road, and Cedar Hills. Oregon Board of Nursing rules allow RNs to place peripheral IVs under physician delegation, and Oregon NPs have full independent practice authority including prescriptive authority. Oregon also has a strong licensed ND scope with IV nutrient authority, which shapes a significant portion of the Beaverton market. Pacific Northwest gray winters drive steady vitamin D demand, and wildfire smoke from Cascade fires drives antioxidant protocol use seasonally.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Oregon medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.